Table 2 Details of prior therapy (Phase II patients)
Patients, N= 54 | % | |
|---|---|---|
Type of prior therapy | ||
Surgery for primary tumour | 47 | 87.0 |
Surgery for metastases | 17 | 31.5 |
Adjuvant chemotherapy | 24 | 44.4 |
Palliative chemotherapy | 54 | 100.0 |
1 Line | 7 | 12.9 |
2 Lines | 11 | 20.4 |
3 Lines | 15 | 27.8 |
⩾ 4 Lines | 21 | 38.9 |
Radiotherapy | 25 | 46.3 |
Failure of previous medication | ||
5-FU | 54 | 100.0 |
Irinotecan | 54 | 100.0 |
Oxaliplatin | 52 | 96.3 |
Bevacizumab | 49 | 90.7 |
Cetuximab | 9 | 16.7 |
